The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
Marijuana studies showed risk for heart patients, unexpected protection for kidneys
There’s more evidence that smoking marijuana can be dangerous for people with heart disease, according to two new studies...
-
Cost of masks and tests deepens a pandemic wedge between the haves and the have-nots
In recent weeks, as the omicron variant spread rapidly across the United States, Americans have found that the financial...
-
‘Forgotten’ Indigenous tribes in Peru’s discover Covid-19 as vaccines arrive
MANGUAL, Peru — Mariano Quisto, a remote community leader in Peru’s dense Amazon rainforest, first learned of the global...
-
A mouthful of nickels? Some say they taste metal after a Covid-19 vaccination
In addition to arm soreness and a little malaise, some people are reporting an unusual side effect following their...
-
Warmer winters mean more tick bites and Lyme disease risk year-round
While most bugs die in the winter, ticks are relatively impervious to the freezing temperatures — and as the...
-
U.S. to ship 144,000 more monkeypox shots and expand testing as cases top 700
The U.S. is stepping up its efforts to address the snowballing monkeypox outbreak — the country’s largest to date...
-
Pfizer says tweaked Covid-19 shots boost omicron protection
Pfizer announced Saturday that tweaking its Covid-19 vaccine to better target the omicron variant is safe and works —...
-
Eight cases of locally transmitted malaria discovered in Florida, Texas
IE 11 is not supported. For an optimal experience visit our site on another browser. China leading global electric...
Recent Comments